$TLYS
TILLY'S, INC. Stock $tlys

$tlys Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023020865 Filed on June 05, 2023

Income Statement

Concept	2023 Q2
Revenue	$123.6M
YoY Change	-15.19%
Cost Of Revenue	$97.70M
YoY Change	-4.18%
Gross Profit	$25.94M
YoY Change	-40.8%
Gross Profit Margin	20.98%
Selling, General & Admin	$43.20M
YoY Change	1.15%
% of Gross Profit	166.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.214M
YoY Change	-8.38%
% of Gross Profit	12.39%
Operating Expenses	$43.20M
YoY Change	1.15%
Operating Profit	-$17.26M
YoY Change	-1657.85%
Interest Expense	$172.0K
YoY Change	588.0%
% of Operating Profit
Other Income/Expense, Net	$1.064M
YoY Change	26500.0%
Pretax Income	-$16.20M
YoY Change	-1556.56%
Income Tax	-$4.200M
% Of Pretax Income
Net Earnings	-$11.97M
YoY Change	-1572.08%
Net Earnings / Revenue	-9.68%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.40
COMMON SHARES
Basic Shares Outstanding	29.80M shares
Diluted Shares Outstanding	29.80M shares

Balance Sheet

Concept	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$93.38M
YoY Change	-15.84%
Cash & Equivalents	$43.69M
Short-Term Investments	$49.70M
Other Short-Term Assets	$9.332M
YoY Change	-36.81%
Inventory	$77.18M
Prepaid Expenses
Receivables	$12.97M
Other Receivables	$0.00
Total Short-Term Assets	$192.9M
YoY Change	-7.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$49.44M
YoY Change	6.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.765M
YoY Change	40.86%
Total Long-Term Assets	$280.3M
YoY Change	0.97%
TOTAL ASSETS
Total Short-Term Assets	$192.9M
Total Long-Term Assets	$280.3M
Total Assets	$473.2M
YoY Change	-2.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$24.73M
YoY Change	-9.06%
Accrued Expenses	$14.25M
YoY Change	-14.86%
Deferred Revenue	$14.79M
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$115.8M
YoY Change	-5.26%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$487.0K
YoY Change	-44.15%
Total Long-Term Liabilities	$191.9M
YoY Change	-1.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$115.8M
Total Long-Term Liabilities	$191.9M
Total Liabilities	$307.7M
YoY Change	-3.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.438M
YoY Change	-1490.79%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$165.5M
YoY Change
Total Liabilities & Shareholders Equity	$473.2M
YoY Change	-2.57%

Cashflow Statement

Concept	2023 Q2
OPERATING ACTIVITIES
Net Income	-$11.97M
YoY Change	-1572.08%
Depreciation, Depletion And Amortization	$3.214M
YoY Change	-8.38%
Cash From Operating Activities	-$16.20M
YoY Change	-7.74%
INVESTING ACTIVITIES
Capital Expenditures	$4.255M
YoY Change	63.78%
Acquisitions
YoY Change
Other Investing Activities	-$9.443M
YoY Change	-120.5%
Cash From Investing Activities	-$13.70M
YoY Change	-131.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$53.00K
YoY Change	-100.65%
NET CHANGE
Cash From Operating Activities	-$16.20M
Cash From Investing Activities	-$13.70M
Cash From Financing Activities	$53.00K
Net Change In Cash	-$29.84M
YoY Change	-268.08%
FREE CASH FLOW
Cash From Operating Activities	-$16.20M
Capital Expenditures	$4.255M
Free Cash Flow	-$20.45M
YoY Change	1.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001524025
CY2023Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-03
CY2023Q2	dei	Document Type DocumentType	10-Q
CY2023Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	dei	Document Period End Date DocumentPeriodEndDate	2023-04-29
CY2023Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity File Number EntityFileNumber	001-35535
CY2023Q2	dei	Entity Registrant Name EntityRegistrantName	TILLY’S, INC.
CY2023Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-2164791
CY2023Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	10 Whatney
CY2023Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
CY2023Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92618
CY2023Q2	dei	City Area Code CityAreaCode	949
CY2023Q2	dei	Local Phone Number LocalPhoneNumber	609-5599
CY2023Q2	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.001 par value per share
CY2023Q2	dei	Trading Symbol TradingSymbol	TLYS
CY2023Q2	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q2	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43686000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	73526000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59954000	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	49695000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	39753000	usd
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	50997000	usd
CY2023Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	12973000	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	9240000	usd
CY2022Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	8209000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	77182000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	62117000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	74112000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9332000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17762000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14769000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	192868000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	202398000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	208041000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	216385000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	212845000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	218163000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49438000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50635000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46606000	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12728000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8497000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11594000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1765000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1377000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1253000	usd
CY2023Q2	us-gaap	Assets Assets	473184000	usd
CY2023Q1	us-gaap	Assets Assets	475752000	usd
CY2022Q2	us-gaap	Assets Assets	485657000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	24730000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	15956000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	27193000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14253000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15889000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16741000	usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	14792000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	16103000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	15150000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9056000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8183000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8707000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	49567000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	48864000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	51237000	usd
CY2023Q2	tlys	Operating Lease Liability Current Related Party OperatingLeaseLiabilityCurrentRelatedParty	2908000	usd
CY2023Q1	tlys	Operating Lease Liability Current Related Party OperatingLeaseLiabilityCurrentRelatedParty	2839000	usd
CY2022Q2	tlys	Operating Lease Liability Current Related Party OperatingLeaseLiabilityCurrentRelatedParty	2483000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	446000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	470000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	674000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	115752000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	108304000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	122185000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	169791000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	167913000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	174301000	usd
CY2023Q2	tlys	Operating Lease Liability Noncurrent Related Party OperatingLeaseLiabilityNoncurrentRelatedParty	21633000	usd
CY2023Q1	tlys	Operating Lease Liability Noncurrent Related Party OperatingLeaseLiabilityNoncurrentRelatedParty	22388000	usd
CY2022Q2	tlys	Operating Lease Liability Noncurrent Related Party OperatingLeaseLiabilityNoncurrentRelatedParty	20364000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	487000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	349000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	872000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	191911000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	190650000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	195537000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	307663000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	298954000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	317722000	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	170608000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	170033000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	167512000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5438000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6530000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	391000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	321000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	205000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	165521000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	176798000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	167935000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	473184000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	475752000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	485657000	usd
CY2023Q2	us-gaap	Revenues Revenues	123637000	usd
CY2022Q2	us-gaap	Revenues Revenues	145775000	usd
CY2023Q2	tlys	Cost Of Goods And Services Sold Excluding Rent CostOfGoodsAndServicesSoldExcludingRent	96768000	usd
CY2022Q2	tlys	Cost Of Goods And Services Sold Excluding Rent CostOfGoodsAndServicesSoldExcludingRent	101100000	usd
CY2023Q2	tlys	Rent Expense Related Party Cost Of Goods Sold RentExpenseRelatedPartyCostOfGoodsSold	931000	usd
CY2022Q2	tlys	Rent Expense Related Party Cost Of Goods Sold RentExpenseRelatedPartyCostOfGoodsSold	860000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	97699000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	101960000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	25938000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	43815000	usd
CY2023Q2	tlys	Selling General And Administrative Expenses Excluding Rent Expense SellingGeneralAndAdministrativeExpensesExcludingRentExpense	43066000	usd
CY2022Q2	tlys	Selling General And Administrative Expenses Excluding Rent Expense SellingGeneralAndAdministrativeExpensesExcludingRentExpense	42574000	usd
CY2023Q2	tlys	Rent Expense Related Party Selling General And Administrative Expenses RentExpenseRelatedPartySellingGeneralAndAdministrativeExpenses	133000	usd
CY2022Q2	tlys	Rent Expense Related Party Selling General And Administrative Expenses RentExpenseRelatedPartySellingGeneralAndAdministrativeExpenses	133000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	43199000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42707000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-17261000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1108000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1064000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16197000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1112000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4229000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	299000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11968000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	813000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29798000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30762000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29798000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31046000	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11968000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	813000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	116000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	116000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11852000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	816000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	176798000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11968000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11968000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	522000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	53000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	116000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	165521000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	174713000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	813000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	563000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	20000	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8177000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	167935000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11968000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	813000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3214000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3508000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	522000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	563000	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	154000	usd
CY2022Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	13000	usd
CY2023Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-16000	usd
CY2022Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-43000	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	295000	usd
CY2022Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	26000	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4231000	usd
CY2022Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-150000	usd
CY2023Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	3683000	usd
CY2022Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	356000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15065000	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8467000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8162000	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1667000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8765000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-955000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	441000	usd
CY2022Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2357000	usd
CY2023Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	873000	usd
CY2022Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-8349000	usd
CY2023Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1616000	usd
CY2022Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1361000	usd
CY2023Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1311000	usd
CY2022Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1946000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-173000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-193000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16195000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17553000	usd
CY2023Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	15081000	usd
CY2022Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	51028000	usd
CY2023Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	24524000	usd
CY2022Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4967000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4255000	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2598000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13698000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	43463000	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8177000	usd
CY2023Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	53000	usd
CY2022Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	20000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8157000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-29840000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17753000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73526000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42201000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43686000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59954000	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-58000	usd
CY2023Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1224000	usd
CY2022Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1108000	usd
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	15327	usd
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	14818	usd
CY2023Q2	us-gaap	Number Of Stores NumberOfStores	248	store
CY2023Q2	tlys	Number Of States NumberOfStates	33	state
CY2023Q2	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Periods</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on the Saturday closest to January 31. References to fiscal 2023 refer to the fiscal year ending February 3, 2024. References to the fiscal quarters or first three months ended April 29, 2023 and April 30, 2022 refer to the thirteen week period ended as of those dates, respectively.</span></div>
CY2023Q2	us-gaap	Revenues Revenues	123637000	usd
CY2022Q2	us-gaap	Revenues Revenues	145775000	usd
CY2023Q2	tlys	Percentage Of Total Net Sales PercentageOfTotalNetSales	1
CY2022Q2	tlys	Percentage Of Total Net Sales PercentageOfTotalNetSales	1
CY2023Q2	tlys	Percentage Of Total Net Sales PercentageOfTotalNetSales	1
CY2022Q2	tlys	Percentage Of Total Net Sales PercentageOfTotalNetSales	1
CY2023Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1800000	usd
CY2023Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1600000	usd
CY2022Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	2100000	usd
CY2023Q2	tlys	Contract With Customer Liability Revenue Recognized Amount Included In Opening Balance ContractWithCustomerLiabilityRevenueRecognizedAmountIncludedInOpeningBalance	2200000	usd
CY2022Q2	tlys	Contract With Customer Liability Revenue Recognized Amount Included In Opening Balance ContractWithCustomerLiabilityRevenueRecognizedAmountIncludedInOpeningBalance	2600000	usd
CY2022	tlys	Unredeemed Awardsand Accumulated Points Expiration Period UnredeemedAwardsandAccumulatedPointsExpirationPeriod	P365D
CY2022Q2	tlys	Unredeemed Awardsand Accumulated Points Expiration Period UnredeemedAwardsandAccumulatedPointsExpirationPeriod	P365D
CY2023Q2	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	-500000	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	4900000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	5000000	usd
CY2022Q2	us-gaap	Deferred Revenue DeferredRevenue	5400000	usd
CY2023Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1600000	usd
CY2022Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	2100000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P10Y
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	51155000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	68000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	59090000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	95000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	49580000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	99000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	38581000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	104000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	30905000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	0	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	63042000	usd
CY2023Q2	tlys	Lessor Operating Lease Payment To Be Received After Year Four LessorOperatingLeasePaymentToBeReceivedAfterYearFour	0	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	292353000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	366000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	48454000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	243899000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	366000	usd
CY2023Q2	tlys	Lessee Operating Lease Not Yet Commenced Amount LesseeOperatingLeaseNotYetCommencedAmount	4300000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	15753000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	15597000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	5777000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	3800000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	21530000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	19397000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	17300000	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	17166000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M12D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M12D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0647
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0608
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4200000	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.261
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.269
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	49310000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	385000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	49695000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	39573000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	180000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	39753000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	50997000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	19000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	19000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	50997000	usd
CY2022Q2	tlys	Numberof Storeswith Impairment NumberofStoreswithImpairment	1	store
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1868243	shares
CY2023Q2	tlys	Non Cash Impairment Charges NonCashImpairmentCharges	200000	usd
CY2022Q2	tlys	Non Cash Impairment Charges NonCashImpairmentCharges	13400	usd
CY2023Q2	tlys	Impaired Long Lived Assets Heldand Used Carrying Amount ImpairedLongLivedAssetsHeldandUsedCarryingAmount	356000	usd
CY2022Q2	tlys	Impaired Long Lived Assets Heldand Used Carrying Amount ImpairedLongLivedAssetsHeldandUsedCarryingAmount	13000	usd
CY2023Q2	tlys	Impaired Long Lived Assets Heldand Used Fair Value ImpairedLongLivedAssetsHeldandUsedFairValue	201000	usd
CY2022Q2	tlys	Impaired Long Lived Assets Heldand Used Fair Value ImpairedLongLivedAssetsHeldandUsedFairValue	0	usd
CY2023Q2	tlys	Numberof Stores Testedfor Impairment NumberofStoresTestedforImpairment	24	store
CY2022Q2	tlys	Numberof Stores Testedfor Impairment NumberofStoresTestedforImpairment	2	store
CY2023Q2	tlys	Numberof Storeswith Impairment NumberofStoreswithImpairment	6	store
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.99
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2500	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.18
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	11000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.86
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	12125	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.89
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	19000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	11.45
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1828618	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.98
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1403000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1136768	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.23
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y1M6D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	930000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.90
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.98
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y2M12D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y2M12D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.586
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.586
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.036
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.023
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29798000	shares
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	522000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	563000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3400000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-11968000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	813000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30762000	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	284000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29798000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31046000	shares
CY2022Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	2000000	shares
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10900000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	741670	shares

Files In Submission

Name	View Source	Status
0001628280-23-020865-index-headers.html	Edgar Link	pending
0001628280-23-020865-index.html	Edgar Link	pending
0001628280-23-020865.txt	Edgar Link	pending
0001628280-23-020865-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
q12023ex311.htm	Edgar Link	pending
q12023ex312.htm	Edgar Link	pending
q12023ex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tlys-20230429.htm	Edgar Link	pending
tlys-20230429.xsd	Edgar Link	pending
tlys-20230429_htm.xml	Edgar Link	completed
tlys-20230429_cal.xml	Edgar Link	unprocessable
tlys-20230429_def.xml	Edgar Link	unprocessable
tlys-20230429_lab.xml	Edgar Link	unprocessable
tlys-20230429_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TLYS
TILLY'S, INC. Stock $tlys

2023 Q2 Form 10-Q Financial Statement

#000162828023020865 Filed on June 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLYS TILLY'S, INC. Stock $tlys

2023 Q2 Form 10-Q Financial Statement

#000162828023020865 Filed on June 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLYS
TILLY'S, INC. Stock $tlys